RecruitingNCT07266142

Prospective Collection of Clinical Data and Human Body Material (HBM) of Cutaneous Melanoma, Non Melanoma Patients and Healthy Controls. Biobank Huidkanker

Prospective Collection of Clinical Data and Human Body Material (HBM): Blood (Serum, Plasma, DNA) and Tissue of Cutaneous Melanoma, Non Melanoma Patients and Healthy Controls. Biobank Huidkanker

Sponsor

Universitaire Ziekenhuizen KU Leuven

Enrollment

7,500 participants

Start Date

Nov 17, 2025

Study Type

OBSERVATIONAL

Conditions

Skin Cancer Melanoma Skin Cancer, Non-Melanoma

Summary

The goal of this clinical trial is to set up a prospective, fit-for-purpose collection of human body material (HBM)-blood (serum, plasma, DNA) and tissue-and standardized clinical data of patients with cutaneous melanoma, non-melanoma skin cancer and healthy controls. The main questions it aims to answer are: * To create a biobank with samples of human body material (HBM): blood (serum/plasma/DNA) and tissue and clinical data of patients with cutaneous melanoma, non-melanoma and helathy controls. * To support future research questions (after specific approval of the Ethics Committee) by using the biobank (through satellite protocols). If there is a comparison group: Not applicable (umbrella protocol for collection only). Participants will: * Share demographics, medical and surgical history, risk factors. * Complete Cancer Worry Scale questionnaire. * Provide biological samples: * Blood samples (serum, plasma, DNA). * Tissue samples (residual tissue or additional biopsy if consented).

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This is a tissue and data collection study (a biobank) for people with skin cancer — both melanoma and non-melanoma types. Researchers are collecting clinical information and biological samples (such as blood or tissue) to better understand skin cancers and improve future treatments. **You may be eligible if...** - You are 18 or older - You have been diagnosed with either melanoma or non-melanoma skin cancer - You are able and willing to provide informed consent **You may NOT be eligible if...** - You are unable or unwilling to give consent Note: Pregnancy is not an automatic exclusion — but may be considered in specific sub-studies within this biobank project. Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.